18-11-2022 | Dapagliflozin | News
People who have heart failure with preserved ejection fraction benefit from dapagliflozin irrespective of whether they have normal or impaired glucose metabolism, shows further analysis of DELIVER.
08-11-2022 | SGLT2 inhibitors | News
A meta-analysis published in The Lancet supports the use of SGLT2 inhibitors in people with chronic kidney disease, irrespective of whether they have type 2 diabetes.
21-10-2022 | Cardiovascular disorders | News
The strength of the association between diabetes and the risk for cardiovascular events has lessened over recent years, report researchers.
25-09-2023 | Gestational diabetes | News
20-09-2023 | Latent autoimmune diabetes of adulthood | News
31-08-2023 | Type 2 diabetes | News
07-07-2023 | Type 2 diabetes | News
22-06-2023 | Cardiovascular outcomes | News
21-06-2023 | Cardiovascular disorders | News
24-04-2023 | Heart failure | News
24-04-2023 | Sulfonylureas | News
10-03-2023 | Primary care | News
08-02-2023 | Heart failure | News